(Post-pandemic Era) - Global Clinical Oncology Next Generation Sequencing (NGS) Market Segment Research Report 2022

(Post-pandemic Era) - Global Clinical Oncology Next Generation Sequencing (NGS) Market Segment Research Report 2022

Table of Contents

Global Clinical Oncology Next Generation Sequencing (NGS) Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market by Value
2.2.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Type
2.2.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market by Value
2.3 Global Clinical Oncology Next Generation Sequencing (NGS) Market by Sales
2.3.1 Global Clinical Oncology Next Generation Sequencing (NGS) Sales by Type
2.3.2 Global Clinical Oncology Next Generation Sequencing (NGS) Market by Sales
3. The Major Driver of Clinical Oncology Next Generation Sequencing (NGS) Industry
3.1 Historical & Forecast Global Clinical Oncology Next Generation Sequencing (NGS) Sales and Revenue (2018-2028)
3.2 Largest Application for Clinical Oncology Next Generation Sequencing (NGS) (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Clinical Oncology Next Generation Sequencing (NGS) Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Clinical Oncology Next Generation Sequencing (NGS) Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Clinical Oncology Next Generation Sequencing (NGS) Average Price Trend
13.1 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in US (2018-2022)
13.2 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Europe (2018-2022)
13.3 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in China (2018-2022)
13.4 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Japan (2018-2022)
13.5 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in India (2018-2022)
13.6 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Korea (2018-2022)
13.7 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Clinical Oncology Next Generation Sequencing (NGS) Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Clinical Oncology Next Generation Sequencing (NGS)
15. Clinical Oncology Next Generation Sequencing (NGS) Competitive Landscape
15.1 Illumina
15.1.1 Illumina Company Profiles
15.1.2 Illumina Product Introduction
15.1.3 Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Roche
15.2.1 Roche Company Profiles
15.2.2 Roche Product Introduction
15.2.3 Roche Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Agilent Technologies
15.3.1 Agilent Technologies Company Profiles
15.3.2 Agilent Technologies Product Introduction
15.3.3 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Knome
15.4.1 Knome Company Profiles
15.4.2 Knome Product Introduction
15.4.3 Knome Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Genomatix Software
15.5.1 Genomatix Software Company Profiles
15.5.2 Genomatix Software Product Introduction
15.5.3 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 GATC Biotech
15.6.1 GATC Biotech Company Profiles
15.6.2 GATC Biotech Product Introduction
15.6.3 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Oxford Nanopore Technologies
15.7.1 Oxford Nanopore Technologies Company Profiles
15.7.2 Oxford Nanopore Technologies Product Introduction
15.7.3 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Macrogen
15.8.1 Macrogen Company Profiles
15.8.2 Macrogen Product Introduction
15.8.3 Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Life Technologies
15.9.1 Life Technologies Company Profiles
15.9.2 Life Technologies Product Introduction
15.9.3 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 DNASTAR
15.10.1 DNASTAR Company Profiles
15.10.2 DNASTAR Product Introduction
15.10.3 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Exosome Diagnostics
15.12 Biomatters
15.13 CLC Bio
15.14 BGI
15.15 Qiagen
15.16 Perkin Elmer
15.17 Pacific Bioscience
15.18 Partek
15.19 GnuBIO
15.20 Foundation Medicine
15.21 Paradigm
15.22 Caris Life Sciences
15.23 Myriad Genetics
16. Conclusion
17. Methodology and Data Source

List of Tables and Figures

Figure 1. Total Sales by Application of Clinical Oncology Next Generation Sequencing (NGS) Industry (Volume)
Figure 2. Clinical Oncology Next Generation Sequencing (NGS) Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Clinical Oncology Next Generation Sequencing (NGS) Revenue in 2022
Figure 5. US Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Clinical Oncology Next Generation Sequencing (NGS) Revenue, by Type (Million USD) (2018-2028)
Table 4. Clinical Oncology Next Generation Sequencing (NGS) Sales, by Type (K Unit) (2018-2028)
Table 5. Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit) by Application (2018-2028)
Table 6. Clinical Oncology Next Generation Sequencing (NGS) Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Clinical Oncology Next Generation Sequencing (NGS) Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Clinical Oncology Next Generation Sequencing (NGS) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Clinical Oncology Next Generation Sequencing (NGS) in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Illumina Profiles
Table 61. Illumina Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 62. Illumina Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Illumina Strategic initiatives
Table 64. Roche Profiles
Table 65. Roche Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 66. Roche Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Roche Strategic initiatives
Table 68. Agilent Technologies Profiles
Table 69. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 70. Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Agilent Technologies Strategic initiatives
Table 72. Knome Profiles
Table 73. Knome Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 74. Knome Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Knome Strategic initiatives
Table 76. Genomatix Software Profiles
Table 77. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 78. Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Genomatix Software Strategic initiatives
Table 80. GATC Biotech Profiles
Table 81. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 82. GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. GATC Biotech Strategic initiatives
Table 84. Oxford Nanopore Technologies Profiles
Table 85. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 86. Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Oxford Nanopore Technologies Strategic initiatives
Table 88. Macrogen Profiles
Table 89. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 90. Macrogen Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Macrogen Strategic initiatives
Table 92. Life Technologies Profiles
Table 93. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 94. Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Life Technologies Strategic initiatives
Table 97. DNASTAR Profiles
Table 98. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 99. DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. DNASTAR Strategic initiatives
Table 101. Exosome Diagnostics Profiles
Table 102. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 103. Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Exosome Diagnostics Strategic initiatives
Table 105. Biomatters Profiles
Table 106. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 107. Biomatters Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Biomatters Strategic initiatives
Table 109. CLC Bio Profiles
Table 110. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 111. CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. CLC Bio Strategic initiatives
Table 113. BGI Profiles
Table 114. BGI Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 115. BGI Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 116. BGI Strategic initiatives
Table 117. Qiagen Profiles
Table 118. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 119. Qiagen Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 120. Qiagen Strategic initiatives
Table 121. Perkin Elmer Profiles
Table 122. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 123. Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 124. Perkin Elmer Strategic initiatives
Table 125. Pacific Bioscience Profiles
Table 126. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 127. Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 128. Pacific Bioscience Strategic initiatives
Table 129. Partek Profiles
Table 130. Partek Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 131. Partek Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 132. Partek Strategic initiatives
Table 133. GnuBIO Profiles
Table 134. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 135. GnuBIO Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 136. GnuBIO Strategic initiatives
Table 137. Foundation Medicine Profiles
Table 138. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 139. Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 140. Foundation Medicine Strategic initiatives
Table 141. Paradigm Profiles
Table 142. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 143. Paradigm Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 144. Paradigm Strategic initiatives
Table 145. Caris Life Sciences Profiles
Table 146. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 147. Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 148. Caris Life Sciences Strategic initiatives
Table 149. Myriad Genetics Profiles
Table 150. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Product Introduction
Table 151. Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 152. Myriad Genetics Strategic initiatives

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs